Why carry out the study?

Patients with moderate-to-severe atopic dermatitis (AD) have a higher prevalence of factors that may increase risk for venous thromboembolism (VTE), yet the risk of VTE among this population is unknown

New therapeutic options in development for patients with moderate-to-severe AD carry a potential risk for VTE

Findings from this study can provide valuable context for understanding VTE risk among patients with AD

What was learned from the study?

This study is the first to provide estimates of VTE incidence rates and comparative risk among a broad population of patients with AD

This study found that AD was not an independent risk factor for VTE, and the risk of VTE among patients with AD was low